Last reviewed · How we verify
NCT04882384
Pericapsular Nerve Group Block for Hip Fractures
NA trial testing Pericapsular Nerve Group Block in Hip Fractures in 10 participants. Completed in 15 March 2022.
15 March 2022
Quick facts
| Lead sponsor | Jacobi Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 1 July 2021 |
| Primary completion | 15 March 2022 |
| Estimated completion | 15 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pericapsular Nerve Group Block
Conditions studied
- Hip Fractures — all drugs for Hip Fractures →
- Pain, Acute — all drugs for Pain, Acute →
Sponsor
Jacobi Medical Center
Who can join
18 and older, any sex, with Hip Fractures or Pain, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04882384
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pericapsular Nerve Group Block
Trials testing the same drug.
- NCT05960253 — Peroperative Effect of Regional Anesthesia in Hip Surgery · NA · unknown
- NCT05912101 — Comparison of the Effects of Pericapsular Nerve Group (PENG), Suprainguinal Fascia Iliaca Compartment (S-FICB) and 3-1 B · NA · unknown
- NCT05154318 — Efficacy of Pericapsular Nerve Group Block · NA · unknown
- NCT05802589 — Comparison of the Efficiency of PENG Block and ESP Block Used for Postoperative Analgesia in Elective Hip Surgery · NA · completed
Other recruiting trials for Hip Fractures
Currently open trials in the same condition.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
- NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04882384 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jacobi Medical Center
- Last refreshed: 21 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04882384.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing